Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zepbound
MedTech
Endoscopic procedure can help slow weight rebound from GLP-1s
A simple outpatient procedure can help those on Eli Lilly’s obesity drug tirzepatide keep most of their weight off when stopping the med.
Ben Adams
Apr 27, 2026 8:48am
BrightGene's oral drug sees up to 8% weight loss in early data
Mar 25, 2026 4:04am
Kailera, Hengrui to advance oral obesity drug into 2 new trials
Feb 10, 2026 9:25am
Lilly's obesity pill maintains weight lost on injectable GLP-1s
Dec 18, 2025 8:20am
Lilly's oral GLP-1 tied to 12% weight loss in phase 3 trial
Aug 7, 2025 6:30am
Scholar Rock's SMA drug helps Zepbound patients retain muscle
Jun 18, 2025 9:10am
